|
STIM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.300400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9046899999986E-05 |
| Normal-vs-Stage2 |
1.273980E-01 |
| Normal-vs-Stage3 |
2.277000E-01 |
| Normal-vs-Stage4 |
6.723800E-01 |
| Stage1-vs-Stage2 |
2.713600E-01 |
| Stage1-vs-Stage3 |
4.578700E-03 |
| Stage1-vs-Stage4 |
1.779260E-03 |
| Stage2-vs-Stage3 |
4.494400E-01 |
| Stage2-vs-Stage4 |
2.430400E-01 |
| Stage3-vs-Stage4 |
5.136800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.607400E-04 |
| Normal-vs-AfricanAmerican |
2.118200E-01 |
| Normal-vs-Asian |
3.366200E-01 |
| Caucasian-vs-AfricanAmerican |
6.120000E-01 |
| Caucasian-vs-Asian |
6.491600E-01 |
| AfricanAmerican-vs-Asian |
5.915400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.089920E-02 |
| Normal-vs-Female |
3.212800E-04 |
| Male-vs-Female |
1.357220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.595200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.362000E-04 |
| Normal-vs-Age(61-80Yrs) |
5.777900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.435800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.266400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.383600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.951200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.293000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.941430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.754400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.346200E-02 |
| Normal-vs-Grade 2 |
8.48590000046556E-07 |
| Normal-vs-Grade 3 |
2.328800E-01 |
| Normal-vs-Grade 4 |
6.601000E-01 |
| Grade 1-vs-Grade 2 |
4.208600E-01 |
| Grade 1-vs-Grade 3 |
8.014200E-02 |
| Grade 1-vs-Grade 4 |
2.393900E-02 |
| Grade 2-vs-Grade 3 |
1.60154999999662E-05 |
| Grade 2-vs-Grade 4 |
9.796500E-04 |
| Grade 3-vs-Grade 4 |
6.368800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.10340000761767E-09 |
| Normal-vs-ccB subtype |
5.306400E-01 |
| ccA subtype-vs-ccB subtype |
2.71029999554528E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.684500E-03 |
| Normal-vs-N1 |
6.093200E-01 |
| N0-vs-N1 |
1.341240E-01 |
|
|
